Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px
Document › Details

UCB S.A.. (10/20/17). "Press Release: UCB First Nine Months Interim Report 2017 – Strong 9 Months Performance Allows for Increase of 2017 Financial Outlook". Brussels.

Organisation Organisation UCB S.A. (Euronext: UCB)
  Group UCB (Group)
Products Product Briviact®
  Product 2 Vimpat®
Persons Person Tellier, Jean-Christophe (201403– CEO-elect joined UCB 2011 before Ipsen + Macrogenics + Novartis)
  Person 2 Witte, Antje (UCB 201601 Investor Relations)
     


   
Record changed: 2017-10-30

Advertisement

Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 600x80px

More documents for UCB (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px




» top